{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T14:40:01Z","timestamp":1739544001715,"version":"3.37.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>The current WHO classification of melanocytic tumors distinguishes 9 pathogenic routes. This classification is based on the conceptual interpretation that melanocytic tumors evolve from benign counterparts, accumulating mutations, eventually developing into melanomas with metastatic and potentially lethal capacity. In this article, we present a molecular study of 2 melanocytic tumors that suggest a \u201cleap\u201d from pathogenic routes IV to I.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>Two recent melanocytic tumors were selected, each exhibiting 2 contiguous melanocytic populations of distinct morphology, without separation between them. One population corresponded to a common melanocytic nevus (with morphology consistent with route I), while the other population displayed epithelioid morphology, consistent with route IV. Immunohistochemical studies were performed in both cases, as well as molecular studies using PCR to search for mutations in the <jats:italic toggle=\"yes\">NRAS<\/jats:italic> and <jats:italic toggle=\"yes\">BRAF<\/jats:italic> genes. For the molecular study, both populations were manually separated by microdissection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In both cases, the melanocytic population consistent with route I showed a <jats:italic toggle=\"yes\">BRAF<\/jats:italic> mutation. In both cases, the epithelioid population did not present a <jats:italic toggle=\"yes\">BRAF<\/jats:italic> mutation. No <jats:italic toggle=\"yes\">NRAS<\/jats:italic> mutations were observed in any of the populations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>These findings suggest the existence of a molecular phenomenon of \u201cleap\u201d between pathways, which we have termed \u201cpathway leap.\u201d This could explain the enigmatic group of tumors that the WHO classifies under the heading of \u201ccombined nevi.\u201d This group could be more frequent than suspected, because microdissection is not a technique commonly used in the daily diagnosis of melanocytic tumors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dad.0000000000002916","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T14:00:12Z","timestamp":1735653612000},"page":"178-183","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["\u201cPathway Leap\u201d: A New Molecular Phenomenon to Consider in the Pathogenesis of Melanocytic Tumors"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-2364","authenticated-orcid":false,"given":"Angel","family":"Fernandez-Flores","sequence":"first","affiliation":[{"name":"Department of Cellular Pathology, Hospital El Bierzo, Ponferrada, Spain;"},{"name":"Department of Cellular Pathology, Hospital de la Reina, Ponferrada, Spain; and"},{"name":"Department of Research. Institute for Biomedical Research of A Coru\u00f1a (INIBIC). University of A Coru\u00f1a (UDC). A Coru\u00f1a, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"R2-20250214","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.3390\/ijms25052984","article-title":"Molecular frontiers in melanoma: pathogenesis, diagnosis, and therapeutic advances","volume":"25","author":"Kim","year":"2024","journal-title":"Int J Mol Sci."},{"key":"R3-20250214","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ad.2023.01.001","article-title":"Modern concepts in melanocytic tumors","volume":"114","author":"Fernandez-Flores","year":"2023","journal-title":"Actas Dermosifiliogr"},{"key":"R4-20250214","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 world health organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway","volume":"144","author":"Elder","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"R5-20250214","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/DAD.0000000000002466","article-title":"Basic concepts in nail pathology","volume":"45","author":"Fernandez-Flores","year":"2023","journal-title":"Am J Dermatopathol"},{"key":"R6-20250214","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pathol.2022.08.007","article-title":"BRAF mutated and morphologically Spitzoid naevus\/atypical Spitz tumour","volume":"55","author":"Wood","year":"2023","journal-title":"Pathology"},{"key":"R7-20250214","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.3390\/ijms23084211","article-title":"The morpho-molecular landscape of Spitz neoplasms","volume":"23","author":"Dal Pozzo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R8-20250214","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/PAS.0000000000001831","article-title":"Benign and intermediate-grade melanocytic tumors with BRAF mutations and spitzoid morphology: a subset of melanocytic neoplasms distinct from melanoma","volume":"46","author":"Zhao","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R9-20250214","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41379-019-0445-z","article-title":"Spitz melanoma is a distinct subset of spitzoid melanoma","volume":"33","author":"Raghavan","year":"2020","journal-title":"Mod Pathol."},{"key":"R10-20250214","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/dermatopathology9020017","article-title":"Conceptual evolution and current approach to Spitz tumors","volume":"9","author":"Urso","year":"2022","journal-title":"Dermatopathology (Basel)"},{"key":"R11-20250214","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/his.14583","article-title":"Spitz melanocytic tumours\u2014a review","volume":"80","author":"Yeh","year":"2022","journal-title":"Histopathology"},{"key":"R12-20250214","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.det.2013.06.012","article-title":"Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview","volume":"31","author":"Ferrara","year":"2013","journal-title":"Dermatol Clin"},{"key":"R14-20250214","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/modpathol.3800653","article-title":"BRAF and NRAS mutations in spitzoid melanocytic lesions","volume":"19","author":"Fullen","year":"2006","journal-title":"Mod Pathol."},{"key":"R15-20250214","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/em.22370","article-title":"Solar ultraviolet-induced DNA damage response: melanocytes story in transformation to environmental melanomagenesis","volume":"61","author":"Sarkar","year":"2020","journal-title":"Environ Mol Mutagen"},{"key":"R16-20250214","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1755-148X.2009.00645.x","article-title":"Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma","volume":"23","author":"Takata","year":"2010","journal-title":"Pigment Cel Melanoma Res."},{"key":"R17-20250214","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/sj.jid.5700366","article-title":"High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi","volume":"126","author":"Ichii-Nakato","year":"2006","journal-title":"J Invest Dermatol."},{"key":"R18-20250214","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/jnci\/djp309","article-title":"Polyclonality of BRAF mutations in acquired melanocytic nevi","volume":"101","author":"Lin","year":"2009","journal-title":"J Natl Cancer Inst."},{"key":"R19-20250214","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jaad.2018.05.005","article-title":"Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors","volume":"79","author":"Garfield","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"R20-20250214","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","article-title":"A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression","volume":"36","author":"Wiesner","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R21-20250214","doi-asserted-by":"crossref","first-page":"155162","DOI":"10.1016\/j.prp.2024.155162","article-title":"Beyond typical histology of BAP1-inactivated melanocytoma","volume":"259","author":"Donati","year":"2024","journal-title":"Pathol Res Pract."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T14:01:07Z","timestamp":1739541667000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002916","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"type":"print","value":"0193-1091"},{"type":"electronic","value":"1533-0311"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}